FREQUENTLY ASKED QUESTIONS IN THE MANAGEMENT OF
CASTRATE-RESISTANT PROSTATE CANCER (CRPC)

An Expert Panel Interview

Educational Objectives

At the conclusion of this activity, participants should be able to:

• Identify patients with castrate-resistant prostate cancer (CRPC)

• Review current and future modalities available for the treatment of CRPC.

• Discuss therapeutic strategies that may mitigate skeletal adverse events associated with metastatic prostate cancer and its treatment.

Faculty

Pamela I. Ellsworth, MD, FACS, Program Chair

Associate Professor of Surgery

Division of Urology

The Warren Alpert Medical School of Brown University

Providence, Rhode Island, USA

Christopher P. Evans, MD, FACS

Professor and Chairman

Department of Urology

University of California, Davis School of Medicine

Sacramento, California, USA

Fred Saad, MD, FRCS

Professor and Chairman of Urology

Director of Urologic Oncology

University of Montreal Endowed Chair in Prostate Cancer

University of Montreal Faculty of Medicine

Montreal, Canada

Presented by the Warren Alpert Medical School of Brown University, Office of Continuing Medical Education. This activity is supported by educational grants from Amgen Inc. and Dendreon Corporation.

Faculty Disclosures

In accordance with the disclosure policy of the Warren Alpert Medical School of Brown University as well as standards set forth by the Accreditation Council for Continuing Medical Education, all speakers and individuals in a position to control the content of a CME activity are required to disclose relevant financial relationships with commercial interests (within the past 12 months). Disclosures of this activity’s speakers and planning committee have been reviewed and all identified conflicts of interest, if applicable, have been resolved.

Pamela I. Ellsworth, MD, is a consultant for Allergan, Inc. and Pfizer Inc; she is a speaker for Pfizer Inc; she has participated in speaker training for Novartis Pharmaceuticals Corporation; and she has participated in clinical research studies sponsored by Novartis Pharmaceuticals Corporation and Pfizer Inc.

Christopher P. Evans, MD, FACS, indicates that he does not have any relevant financial relationships.

Fred Saad, MD, FRCS, has indicated that he has received grant/research support from and has served as a consultant for Amgen and Novartis Pharmaceuticals Corporation.

Accreditation Statement

This activity has been planned and implemented in accordance with the Essential Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the Warren Alpert Medical School of Brown University, and Health and Wellness Education Partners. The Alpert Medical School is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Statement of Responsibility

The Warren Alpert Medical School of Brown University takes responsibility for the content, quality, and scientific integrity of this CME activity.

Credit Designation Statement

The Alpert Medical School designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only credit commensurate with the extent of their participation in the activity.

Program Release: April 1, 2011

Program Expiration: April 30, 2012

Estimated time to complete: 60 minutes

There are no prerequisites for participation.

Target Audience

This activity is designed for urologists and other healthcare professionals interested in or involved with the management of prostate cancer.

CME Credit

For receipt of CME credit, an evaluation and posttest must be completed at the conclusion of the activity. A minimum score of 75% is required to receive a CME credit certificate.

The Office of Continuing Medical Education (CME) is committed to protect the privacy of its members and customers. The CME Office maintains its Internet site as an information resource and service for physicians, other health professionals, and the public. The CME Office will keep your personal information confidential when you participate in a CME Internet-based program. CME collects only the information necessary to provide you with the services that you request.

The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own. This enduring material is produced for educational purposes only. The use of the Warren Alpert Medical School of Brown University name implies review of educational format, design, and approach. Please review the complete prescribing information of specific drugs or combination of drugs including indications, contraindications, warnings, and adverse effects before administering pharmacologic therapy to patients.

AAPA Credit

AAPA accepts certificates of participation for educational activities certified for Category 1 credit from AOACCME, prescribed credit from AAFP, and AMA PRA Category 1 Credit™ from organizations accredited by ACCME or a recognized state medical society. Physician assistants may receive a maximum of 1.0 hour of Category 1 credit for completing this program.

To Receive CME Credit

To complete the posttest and evaluation for this activity and receive CME credit, click here.